Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices

Autores
Aleman, Alicia; Cafferata, Maria L; Gibbons, Luz; Althabe, Fernando; Ortiz, Jose; Sandoval, Xochitl; Padilla Raygoza, Nicolás; Belizan, Jose
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America. Methods: This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used. Results: The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication. Conclusions: This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.
Fil: Aleman, Alicia. Universidad de la República; Uruguay
Fil: Cafferata, Maria L. Unidad de Investigación Clínica y Epidemiológica; Uruguay
Fil: Gibbons, Luz. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Ortiz, Jose. Universidad de Cuenca; Ecuador
Fil: Sandoval, Xochitl. Universidad de El Salvador; El Salvador
Fil: Padilla Raygoza, Nicolás. Universidad de Guanajuato; México
Fil: Belizan, Jose. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
Materia
ANTENATAL CORTICOSTEROIDS
PRETERM BIRTH
RESPIRATORY DISTRESS SYNDROME/PREVENTION
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/78407

id CONICETDig_43ba606d37af3a2c333e3cd39f83967a
oai_identifier_str oai:ri.conicet.gov.ar:11336/78407
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practicesAleman, AliciaCafferata, Maria LGibbons, LuzAlthabe, FernandoOrtiz, JoseSandoval, XochitlPadilla Raygoza, NicolásBelizan, JoseANTENATAL CORTICOSTEROIDSPRETERM BIRTHRESPIRATORY DISTRESS SYNDROME/PREVENTIONhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America. Methods: This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used. Results: The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication. Conclusions: This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.Fil: Aleman, Alicia. Universidad de la República; UruguayFil: Cafferata, Maria L. Unidad de Investigación Clínica y Epidemiológica; UruguayFil: Gibbons, Luz. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Ortiz, Jose. Universidad de Cuenca; EcuadorFil: Sandoval, Xochitl. Universidad de El Salvador; El SalvadorFil: Padilla Raygoza, Nicolás. Universidad de Guanajuato; MéxicoFil: Belizan, Jose. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; ArgentinaBioMed Central2013-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/78407Aleman, Alicia; Cafferata, Maria L; Gibbons, Luz; Althabe, Fernando; Ortiz, Jose; et al.; Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices; BioMed Central; Reproductive Health; 10; 1; 1-2013; 10-140968-80801742-4755CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/1742-4755-10-4info:eu-repo/semantics/altIdentifier/url/https://reproductive-health-journal.biomedcentral.com/articles/10.1186/1742-4755-10-4info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598882/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:12:08Zoai:ri.conicet.gov.ar:11336/78407instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:12:08.888CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
title Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
spellingShingle Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
Aleman, Alicia
ANTENATAL CORTICOSTEROIDS
PRETERM BIRTH
RESPIRATORY DISTRESS SYNDROME/PREVENTION
title_short Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
title_full Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
title_fullStr Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
title_full_unstemmed Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
title_sort Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices
dc.creator.none.fl_str_mv Aleman, Alicia
Cafferata, Maria L
Gibbons, Luz
Althabe, Fernando
Ortiz, Jose
Sandoval, Xochitl
Padilla Raygoza, Nicolás
Belizan, Jose
author Aleman, Alicia
author_facet Aleman, Alicia
Cafferata, Maria L
Gibbons, Luz
Althabe, Fernando
Ortiz, Jose
Sandoval, Xochitl
Padilla Raygoza, Nicolás
Belizan, Jose
author_role author
author2 Cafferata, Maria L
Gibbons, Luz
Althabe, Fernando
Ortiz, Jose
Sandoval, Xochitl
Padilla Raygoza, Nicolás
Belizan, Jose
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ANTENATAL CORTICOSTEROIDS
PRETERM BIRTH
RESPIRATORY DISTRESS SYNDROME/PREVENTION
topic ANTENATAL CORTICOSTEROIDS
PRETERM BIRTH
RESPIRATORY DISTRESS SYNDROME/PREVENTION
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background: Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America. Methods: This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used. Results: The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication. Conclusions: This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.
Fil: Aleman, Alicia. Universidad de la República; Uruguay
Fil: Cafferata, Maria L. Unidad de Investigación Clínica y Epidemiológica; Uruguay
Fil: Gibbons, Luz. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Ortiz, Jose. Universidad de Cuenca; Ecuador
Fil: Sandoval, Xochitl. Universidad de El Salvador; El Salvador
Fil: Padilla Raygoza, Nicolás. Universidad de Guanajuato; México
Fil: Belizan, Jose. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
description Background: Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America. Methods: This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used. Results: The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication. Conclusions: This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.
publishDate 2013
dc.date.none.fl_str_mv 2013-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/78407
Aleman, Alicia; Cafferata, Maria L; Gibbons, Luz; Althabe, Fernando; Ortiz, Jose; et al.; Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices; BioMed Central; Reproductive Health; 10; 1; 1-2013; 10-14
0968-8080
1742-4755
CONICET Digital
CONICET
url http://hdl.handle.net/11336/78407
identifier_str_mv Aleman, Alicia; Cafferata, Maria L; Gibbons, Luz; Althabe, Fernando; Ortiz, Jose; et al.; Use of antenatal corticosteroids for preterm birth in Latin America: Providers knowledge, attitudes and practices; BioMed Central; Reproductive Health; 10; 1; 1-2013; 10-14
0968-8080
1742-4755
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/1742-4755-10-4
info:eu-repo/semantics/altIdentifier/url/https://reproductive-health-journal.biomedcentral.com/articles/10.1186/1742-4755-10-4
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598882/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842980630448570368
score 12.993085